- Home
- NLSP vs FDBC Comparison
NLSP vs FDBC Comparison
Compare NLSP & FDBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NLSP
- FDBC
- Stock Information
- Founded
- NLSP 2015
- FDBC 1902
- Country
- NLSP Switzerland
- FDBC United States
- Employees
- NLSP N/A
- FDBC N/A
- Industry
- NLSP Biotechnology: Pharmaceutical Preparations
- FDBC Major Banks
- Sector
- NLSP Health Care
- FDBC Finance
- Exchange
- NLSP Nasdaq
- FDBC Nasdaq
- Market Cap
- NLSP 12.4M
- FDBC 238.0M
- IPO Year
- NLSP 2021
- FDBC N/A
- Fundamental
- Price
- NLSP $2.86
- FDBC $46.01
- Analyst Decision
- NLSP
- FDBC
- Analyst Count
- NLSP 0
- FDBC 0
- Target Price
- NLSP N/A
- FDBC N/A
- AVG Volume (30 Days)
- NLSP 365.2K
- FDBC 7.5K
- Earning Date
- NLSP 07-07-2025
- FDBC 07-23-2025
- Dividend Yield
- NLSP N/A
- FDBC 3.44%
- EPS Growth
- NLSP N/A
- FDBC 32.34
- EPS
- NLSP N/A
- FDBC 3.75
- Revenue
- NLSP N/A
- FDBC $81,316,000.00
- Revenue This Year
- NLSP N/A
- FDBC N/A
- Revenue Next Year
- NLSP N/A
- FDBC N/A
- P/E Ratio
- NLSP N/A
- FDBC $12.27
- Revenue Growth
- NLSP N/A
- FDBC 15.07
- 52 Week Low
- NLSP $1.30
- FDBC $37.00
- 52 Week High
- NLSP $15.59
- FDBC $61.21
- Technical
- Relative Strength Index (RSI)
- NLSP 67.56
- FDBC 59.13
- Support Level
- NLSP $2.19
- FDBC $42.02
- Resistance Level
- NLSP $2.54
- FDBC $43.50
- Average True Range (ATR)
- NLSP 0.19
- FDBC 0.98
- MACD
- NLSP 0.02
- FDBC 0.24
- Stochastic Oscillator
- NLSP 82.76
- FDBC 95.26
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd a clinical-stage biopharmaceutical company focused on the discovery and development of inventive therapies for patients with rare and complex CNS disorders with unmet medical needs. Its compound, mazindol, a triple monoamine reuptake inhibitor and partial orexin receptor 2 agonist, in a proprietary ER formulation, is being developed for the treatment of narcolepsy, IH (follow-on indication), and potentially ADHD (back-up indication). Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.
About FDBC Fidelity D & D Bancorp Inc.
Fidelity D & D Bancorp Inc is a bank holding company. Through its wholly-owned state-chartered commercial bank subsidiary, The Fidelity Deposit and Discount Bank (the Bank), it offers a full range of traditional banking services. The Bank has a personal and corporate trust department and also provides alternative financial and insurance products with asset management services. Its primary market areas are Lackawanna, Luzerne and Northampton Counties, Pennsylvania. The company's primary deposit products are demand deposits and interest-bearing time, money market and savings accounts. It offers a full array of loan products to meet the needs of retail and commercial customers. Company includes segments: Commercial and Industrial, Commercial Real Estate, Consumer, Residential Real Estate.